Navigation Links
Pharmaceutical, Biotech Research Companies Support Newark Rx Assistance Program
Date:9/22/2009

WASHINGTON, Sept. 22 /PRNewswire-USNewswire/ -- The City of Newark, New Jersey, today launched Newark Rx with the support of a number of America's pharmaceutical research and biotechnology companies. The program is designed to deliver free or nearly free medicines to the uninsured and low-income patients who do not qualify for Medicaid.

"The Pharmaceutical Research and Manufacturers of America (PhRMA) and its member companies are proud to be able to work with Newark Mayor Cory Booker, Heinz Family Philanthropies, the Health Care Institute of New Jersey and other partners to help city residents obtain the medicines they need," said PhRMA Vice President Jan Faiks. "Newark Rx targets patients with household incomes at or below 200 percent of the federal poverty level, which is about $21,660 a year for an individual and $44,100 annually for a family of four."

Faiks stressed that the patients who will be helped often suffer the debilitating effects of common chronic diseases and because of that, "it is essential that they obtain medicines that can either prevent deterioration to full-blown disease or manage medical conditions when they develop."

Studies show that when patients combine healthy diet and exercise with taking medicines as prescribed, they often avoid expensive surgeries and hospitalizations. "That helps them live more productive lives and helps the city of Newark and state of New Jersey save money," Faiks said.

She cited a 2007 study published in the journal Health Affairs by researchers at Harvard and the Massachusetts Institute of Technology (MIT) that found high blood pressure medicines prevented 86,000 deaths in America in 2001 and 833,000 hospitalizations in 2002. The same researchers also estimated that if all patients suffering from high blood pressure took their medications as prescribed, an additional 89,000 deaths and 420,000 hospitalizations could be avoided annually, saving $16.5 billion from fewer strokes and heart attacks.

Faiks noted that the participation of PhRMA and its member companies in Newark Rx is in keeping with a long tradition of helping struggling patients obtain their medicines. The companies supporting Newark Rx have also sponsored their own medication assistance programs for decades and PhRMA has been sponsoring the Partnership for Prescription Assistance (PPA) since April 2005.

The PPA is a single point of access to more than 475 patient assistance programs, including nearly 200 sponsored by America's pharmaceutical research and biotechnology companies. The programs provide medicines for free or nearly free to uninsured patients and those who are struggling financially. Patients all over America can access the PPA by calling a toll-free number (1-888-477-2669) to talk to a trained operator or accessing the Web site (www.pparx.org). It takes about 15 minutes for patients to find out if they may qualify for help.

So far, the PPA has helped nearly 6 million Americans nationwide. In New Jersey, almost 250,000 residents have been helped by the PPA and its pilot program, Rx for New Jersey. Forty-five towns and cities from all over the state have been visited by the PPA's "Help Is Here Express" bus.

"And now," said Faiks, "Newark Rx has been launched to help uninsured and low-income city residents obtain their badly needed medications. We applaud the city and Heinz Family Philanthropies for also launching NewarkHealthPlus to contract with local physicians to create medical homes for the uninsured and under-insured. The program should lead to less reliance on hospital emergency rooms for primary care."

Faiks emphasized that from providing prescription medications to quality care by local doctors, "the city of Newark has embarked on an ambitious effort to help residents live longer, healthier and more productive lives. PhRMA and its member companies are proud to be part of the mission."

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For more information on public health emergencies, visit http://www.rxresponse.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
2. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
3. Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
4. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
5. BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
8. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
9. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynchs Global Pharmaceutical, Biotechnology and Medical Device Conference
11. 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , ... July 21, 2017 , ... The Ellis Agency, ... with the Epilepsy Foundation in a community wide charity event with the goal of ... Sunde, a young local woman who lives with epilepsy, recently launched a charity campaign ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... and Theater of Witness , was awarded a $300,000 grant from ... program which fosters empathy, comfort with ambiguity and the recognition of one’s own ...
(Date:7/21/2017)... Basking Ridge, NJ (PRWEB) , ... July 21, ... ... Hills (VNA) has received a $5,000 grant from the C. R. ... Adult Day Center at Somerset Hills , a service available through the ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated ... life a decade after surgery, though activity levels decline over time. The study, ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... -- The tenth annual BioPharm America™ will take ... the Sheraton Boston Hotel, September 26–27. The event will ... makers and innovative biotech startup companies. The event is ... impactful days. BioPharm America is now part of Biotech ... with 4,500+ life science industry influencers participating in 8+ ...
(Date:7/5/2017)... Pace Analytical, a company of over 2,000 employees and a leader in environmental ... Sciences, further solidifying their position as the top American owned and operated environmental ... ... Analytical ... Mt Juliet, TN , enhances Pace Analytical,s capability as an innovative full ...
(Date:6/30/2017)... -- Axium Pharmaceuticals Inc. is a pharmaceutical company aimed at utilizing drug ... forms of existing biologically active molecule. ... Subveta oral spray ... formula, which is designed to prevent precipitation of the active ... provide fast onset of action and is designed to optimize ...
Breaking Medicine Technology: